Literature DB >> 28397875

Treatment of NASH: What Helps Beyond Weight Loss?

Bubu A Banini1, Arun J Sanyal1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28397875     DOI: 10.1038/ajg.2017.83

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  17 in total

Review 1.  Gastrointestinal surgery for severe obesity. Proceedings of a National Institutes of Health Consensus Development Conference. March 25-27, 1991, Bethesda, MD.

Authors: 
Journal:  Am J Clin Nutr       Date:  1992-02       Impact factor: 7.045

2.  Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.

Authors:  Anil Arora; Praveen Sharma
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

3.  Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis.

Authors:  E Boettcher; G Csako; F Pucino; R Wesley; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2011-11-04       Impact factor: 8.171

4.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

5.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Naga Chalasani; Kris V Kowdley; Arthur McCullough; Anna Mae Diehl; Nathan M Bass; Brent A Neuschwander-Tetri; Joel E Lavine; James Tonascia; Aynur Unalp; Mark Van Natta; Jeanne Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  N Engl J Med       Date:  2010-04-28       Impact factor: 91.245

6.  Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis.

Authors:  Andrew A Taitano; Michael Markow; Jon E Finan; Donald E Wheeler; John Paul Gonzalvo; Michel M Murr
Journal:  J Gastrointest Surg       Date:  2014-12-24       Impact factor: 3.452

Review 7.  A Systematic Review of Bariatric Surgery in Patients with Liver Cirrhosis.

Authors:  Ahmad Jan; Mahendra Narwaria; Kamal K Mahawar
Journal:  Obes Surg       Date:  2015-08       Impact factor: 4.129

8.  Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.

Authors:  James D Lewis; Laurel A Habel; Charles P Quesenberry; Brian L Strom; Tiffany Peng; Monique M Hedderson; Samantha F Ehrlich; Ronac Mamtani; Warren Bilker; David J Vaughn; Lisa Nessel; Stephen K Van Den Eeden; Assiamira Ferrara
Journal:  JAMA       Date:  2015-07-21       Impact factor: 56.272

9.  Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.

Authors:  Mattias Ekstedt; Lennart E Franzén; Marika Holmqvist; Preben Bendtsen; Ulrik L Mathiesen; Göran Bodemar; Stergios Kechagias
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

10.  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Amy G Shah; Alison Lydecker; Karen Murray; Brent N Tetri; Melissa J Contos; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-10       Impact factor: 11.382

View more
  3 in total

1.  Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide.

Authors:  Neil D Shah; Meritxell Ventura-Cots; Juan G Abraldes; Mohamed Alboraie; Ahmad Alfadhli; Josepmaria Argemi; Ester Badia-Aranda; Enrique Arús-Soler; A Sidney Barritt; Fernando Bessone; Marina Biryukova; Flair J Carrilho; Marlen Castellanos Fernández; Zaily Dorta Guiridi; Mohamed El Kassas; Teo Eng-Kiong; Alberto Queiroz Farias; Jacob George; Wenfang Gui; Prem H Thurairajah; John Chen Hsiang; Azra Husić-Selimovic; Vasily Isakov; Mercy Karoney; Won Kim; Johannes Kluwe; Rakesh Kochhar; Narendra Dhaka; Pedro Marques Costa; Mariana A Nabeshima Pharm; Suzane K Ono; Daniela Reis; Agustina Rodil; Caridad Ruenes Domech; Federico Sáez-Royuela; Christoph Scheurich; Way Siow; Nadja Sivac-Burina; Edna Solange Dos Santos Traquino; Fatma Some; Sanjin Spreckic; Shiyun Tan; Julio Vorobioff; Andrew Wandera; Pengbo Wu; Mohamed Yacoub; Ling Yang; Yuanjie Yu; Nerma Zahiragic; Chaoqun Zhang; Helena Cortez-Pinto; Ramon Bataller
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-29       Impact factor: 11.382

2.  Associations of weight loss with obesity-related comorbidities in a large integrated health system.

Authors:  Arshiya Mariam; Galen Miller-Atkins; Kevin M Pantalone; Neeraj Iyer; Anita D Misra-Hebert; Alex Milinovich; Janine Bauman; Michelle Mocarski; Abhilasha Ramasamy; B Gabriel Smolarz; Todd M Hobbs; Robert S Zimmerman; Bartolome Burguera; Michael W Kattan; Daniel M Rotroff
Journal:  Diabetes Obes Metab       Date:  2021-09-28       Impact factor: 6.408

3.  ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs.

Authors:  Cynthia R L Webster; Sharon A Center; John M Cullen; Dominique G Penninck; Keith P Richter; David C Twedt; Penny J Watson
Journal:  J Vet Intern Med       Date:  2019-03-07       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.